콘텐츠로 건너뛰기
Merck
  • Multidrug-resistant tuberculosis that required 2 years for diagnosis.

Multidrug-resistant tuberculosis that required 2 years for diagnosis.

BMJ case reports (2012-05-19)
Shuichi Yano, Kanako Kobayashi, Toshikazu Ikeda
초록

Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Sodium 4-aminosalicylate dihydrate, ≥97.0% (T)
Sigma-Aldrich
4-Aminosalicylic acid, 99%